Avacta Group plc Affimer®



Affimer reagents and therapeutics are a class of non-antibody binding proteins that have been engineered for a wide range of applications where antibodies and aptamers have limitations. They can be used to detect difficult targets, can easily be formatted for a wide range of applications and can be easily and cost effectively manufactured.  
Two Affimer scaffolds, based on similar protein conformations, have been developed. The first is of human origin, based on the naturally occurring human protease inhibitor Stefin A, and is ideal for therapeutic applications. The second is based on a consensus sequence of Cystatin A from a number of plant species and is ideal for use in reagents and diagnostics.



Manuals and Resources

Note: We appreciate the support of individuals and companies making their documents and resources available to our community. If you find a document or resource that does not belong please let us know by emailing

Picture of Avacta Group plc Affimer®
Our mission is to shape the future of medicine by developing safe and efficacious drugs based on our proprietary Affimer® platform and by providing...

More about Avacta Group plc

Visit Avacta Group plc

Questions and Answers

Recent Question Activity

Be the first to Ask a Question


Member Reviews

There are no threads in Avacta Group plc Affimer® Reviews at this time.
Add a Review

Avacta Group plc Affimer® Articles

Helpful Resources, Articles, and Information

Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, and OncoSec Medical Incorporated ("OncoSec")...

See All Related Articles